Birlasoft Ltd

- There is no mention of any current or future plans for fundraising through debt or equity in the provided transcript. - The management focuses on capital allocation and enhancing operating efficiencies but has not indicated any intention to raise funds via debt or equity. - The Board of Directors is actively considering capital allocation strategies, including opportunistic investments and possible buybacks, but no specific fundraising plans are disclosed. - Emphasis is placed on using the existing cash pile (Rs. 2,491 crore at end of Q3) to invest in growth and capabilities. - The company is prioritizing sustaining margins and improving quality of revenue through internal investments rather than external fundraising.

- The company is focused on ongoing investments in capabilities necessary for future growth, particularly in people, leadership, and training resources aligned with business strategy. (Page 14) - Investments include growth-oriented areas such as the ROW region, which has recently delivered significant growth and margin improvement. (Page 16) - There is a strategic emphasis on moving away from staff augmentation towards more linear, outcome-based, and fixed-price deals, which supports offshore expansion and margin improvement. (Page 6) - The Board is actively engaged in capital allocation decisions, including opportunistic capabilities and investments that align with strategic objectives; no specific buyback plans are confirmed yet. (Page 16) - New leadership appointments (e.g., Komal for Americas) indicate increased investment in driving critical relationships and growing key markets. (Page 16)

- Q4 growth expected to be soft in Manufacturing and ERP segments due to one-off deal ramp-ups ending and lesser working days. - Management cautiously optimistic for Q4; confident about better deal wins and order bookings than Q3. - 10%-20% higher signings in Q4 over Q3 could ensure definite growth moving forward. - Healthcare segment faces pricing pressure but no volume degrowth expected in Q4 and partly in Q1 FY27. - Manufacturing headwinds may continue into Q4 but expected to stabilize and grow from Q1 or Q2 FY27. - Energy & Utilities (E&U) and Financial Services segments show steady growth momentum. - Shift towards fixed-price, outcome-based deals to reduce volume impact from fewer working days and improve margins. - Investments focused on sales, solutions, delivery capabilities to build pipeline and drive sustained revenue growth over coming quarters.

- Management is focused on driving order book and revenue growth going forward, addressing past lack of strong growth. - Q4 growth is expected to be soft in Manufacturing and ERP segments due to one-off factors and lesser working days. - Confident that growth will return in future quarters with better deal signings; delivering 10-20% higher signings in Q4 compared to Q3 would signal growth. - EBITDA margin sustainable run rate expected around 15%, after accounting for one-offs and continuous investments in capabilities. - Investments focus on people, leadership, and capability building without relying on margin concessions. - Wage hikes planned for next financial year between Q1 and Q2. - Some pricing pressure anticipated in Healthcare due to client uncertainties but no volume decline expected. - Order booking for Q4 expected to be better than Q3; Q1 anticipated to be seasonally weaker for signings.

- The company maintains that H2 (second half) will be better than H1 regarding signings. - Q3 and Q4 order booking performance is expected to be an indication of improving order book. - Q4 is expected to deliver better order booking than Q3. - The focus is sharply on order book and revenue growth moving forward. - Pipeline creation and deal wins are being actively pursued to drive order book and revenue. - Deal wins in Q3 were strong, with $202 million TCV, up 89% quarter-on-quarter. - New engagements contribute nearly half of the deal wins. - The 4Q order intake is expected to be better, but revenue growth guidance is cautiously optimistic.